Ophthalmic Plastic and Reconstructive Surgery · Mobile, AL
NPI
1114999729
Since 2006
Specialty
Ophthalmic Plastic and Reconstructive Surgery
Code 207WX0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
6576 Airport Blvd Ste B200
Mobile, AL, 36608
Phone (251) 650-5437
Groups this clinician bills Medicare through
Medicare paid, 2024
$156K
2,700 services
Medicare patients, 2024
333
Average age 74
Drug cost, 2024
$719K
605 prescriptions
Company payments, 2025
$504
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark S Brown was code 92285 (standard x-ray), 352 times for 314 patients. In total Mark S Brown billed 2,700 services in 46 codes, and Medicare paid $156K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92285 Standard X-ray | Office | 352 | 314 | $13.23 | $4,656 |
| 99214 Office E&M - Established | Office | 249 | 163 | $86.26 | $21K |
| 99204 Office E&M - New | Office | 191 | 191 | $112.88 | $22K |
| 92083 Vision, Hearing, and Speech Services | Office | 143 | 134 | $42.32 | $6,052 |
| 15823 Skin | Facility | 70 | 70 | $600.66 | $42K |
| 92060 Vision, Hearing, and Speech Services | Office | 40 | 25 | $43.51 | $1,740 |
| 67840 Eye | Office | 36 | 33 | $195.28 | $7,030 |
| 67903 Eye | Facility | 23 | 23 | $507.63 | $12K |
| 67875 Eye | Facility | 23 | 23 | $43.85 | $1,009 |
By year: 2022 $162K for 3,322 services; 2023 $148K for 2,791 services; 2024 $156K for 2,700 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark S Brown prescribed most often to Medicare patients was Doxycycline Hyclate, with 333 prescriptions and refills. In total Mark S Brown wrote 605 Medicare prescriptions that cost $719K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxycycline Hyclate Generic | 333 | 751 | 144 | $13K |
| Erythromycin Erythromycin Base | 115 | 115 | 102 | $1,250 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 51 | 51 | 33 | $682 |
| Prednisolone Acetate Generic | 22 | 26 | 20 | $1,063 |
| Tepezza Teprotumumab-Trbw | 11 | 11 | Under 11 | $700K |
Brand drugs: 64 claims; generic drugs: 541 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark S Brown $504 ($504 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $504.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 26 | $504 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.